Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3526

Actual shortage: 232 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 11 (0%)
Resolved: 3280 (93%)

Discontinuation Reports

366

To be discontinued: 24 (7%)
Discontinued: 342 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

32 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OVIMA 28 30MCG 150MCG TABLET Resolved 2022-01-07 2022-02-07 152329
OVIMA 28 30MCG 150MCG TABLET Resolved 2023-03-02 2023-03-23 185933
APO-PENTOXIFYLLINE SR 400MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-29 2022-07-23 159738
APO-PENTOXIFYLLINE SR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-07 2025-01-13 239503
APO-PENTOXIFYLLINE SR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-06-20 2025-09-27 260720
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 3.0G 0.375G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 577
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 4.0G 0.5G POWDER FOR SOLUTION Actual shortage 2017-03-11 2017-10-05 580
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2G 0.25G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 583
TIGECYCLINE 50MG POWDER FOR SOLUTION Resolved 2018-01-17 2018-08-22 36356
APO-TIZANIDINE 4MG TABLET Resolved 2019-04-29 2019-05-27 82759
APO-TRAMADOL 50MG TABLET Resolved 2018-01-09 2018-02-01 35364
APO-TRAMADOL 50MG TABLET Resolved 2019-03-06 2019-03-21 77928
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2022-12-02 2023-03-16 176945
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-04-06 2023-08-12 188979
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2024-01-05 2024-02-02 215236
TRI-CIRA 28 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-03-23 2023-08-12 187715
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-10-28 2023-04-14 172942
TRI-CIRA LO 21 0.18MG 0.025MG 0.025MG 0.25MG 0.025MG 0.215MG TABLET Resolved 2025-07-31 2025-08-15 263987
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-01-18 2018-02-23 36429

Showing 3481 to 3500 of 3526

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-FENTANYL MATRIX 100MCG PATCH Discontinued 2018-02-23 2018-12-28 40741
APO-FENTANYL MATRIX 25MCG PATCH Discontinued 2018-09-07 2018-09-15 60489
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497
APO-FLUNISOLIDE NASAL SPRAY 0.25MG METERED-DOSE PUMP Discontinued 2018-02-26 2018-02-26 40965
APO-FLUVOXAMINE 100MG TABLET Discontinued 2017-03-30 2018-02-05 4713
APO-FLUVOXAMINE 50MG TABLET Discontinued 2017-03-30 2018-02-05 4716
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2018-02-26 2018-02-26 40997
APO-GAIN LIQ 20MG/ML 20MG SOLUTION Discontinued 2019-01-02 2019-01-02 70815
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-GEMFIBROZIL CAP 300MG USP 300MG CAPSULE Discontinued 2017-03-31 2018-12-07 4920
APO-GEMFIBROZIL CAP 300MG USP Discontinued 2019-06-12 2019-06-12 86557
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94446
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94449
APO-GLIMEPIRIDE Discontinued 2019-09-20 2019-09-20 94452
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959

Showing 161 to 180 of 366